RiverTree Advisors’s Eli Lilly LLY Stock Holding History

RiverTree Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,229	Closed	-$977K	–	45
2021 Q3	$977K	Buy	+4,229	New	+$1.04M	0.67%	36

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RiverTree Advisors's LLY Position: Q4 2021 in Review

RiverTree Advisors sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 4,229 shares — an estimated $977K sold.

RiverTree Advisors first reported a position in LLY in Q3 2021 and held it in 1 quarter. The position peaked at $977K in Q3 2021. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

RiverTree Advisors reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
RiverTree Advisors sold 4,229 Eli Lilly shares in Q4 2021, an estimated $977K.
RiverTree Advisors first reported a position in Eli Lilly in Q3 2021 and held it in 1 quarter.
RiverTree Advisors's Eli Lilly position peaked at $977K in Q3 2021.
2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on RiverTree Advisors's 13F filing for Q4 2021, filed 18 Jan 2022.